Radiation therapy firm Accuray has signed a collaboration agreement with C-RAD to incorporate C-RAD's Catalyst+ HD software into Accuray's Radixact breast cancer radiation therapy treatment system.
Catalyst+ HD provides tools for patient positioning, motion management, and respiratory gating, Accuray said. C-RAD is also developing deep inspiration breath hold capability for Catalyst+ HD.
The two firms expect the integrated system to be available mid-2022.
![A 53-year-old patient (patient number four) with a recurrent pituitary adenoma with extension of a cystic component of disease to the medial temporal lobe apparent on MRI (contoured in blue), and extension of disease to the left sphenoid bone and orbital apex apparent on [68Ga]Ga-DOTA-TATE (contoured in yellow).](https://img.auntminnie.com/mindful/smg/workspaces/default/uploads/2026/04/pituitary-tumor.QGsEnyB4bU.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
